A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy
A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy
A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy
Statut
Status :
Terminé
Type d'étude
Phase I
Age Min.
-
Age Max.
-
Genre
Tous
Aire thérapeutique :
Dermatologie
Maladie :
Hémangiome infantile
Traitement :
Propranolol (Hemangiol®)
Phase :
Phase I
Date de début de l'étude :
26 Mars 2010
End date :
29 Mai 2012
Identifiant de l'essai :
V00400 SB 102
Identifiant EudraCT/CTIS :
2009-018102-22
Envoyer par email